← Return to 1st PSA test seven weeks after surgery

Discussion
johndavis60 avatar

1st PSA test seven weeks after surgery

Prostate Cancer | Last Active: Jul 25 3:06pm | Replies (44)
Comment receiving replies
Profile picture for jeff Marchi @jeffmarc

To: @thmssllvn

Zytiga has been used for hormone sensitive patients for a long time, Probably from its inception. I was on it for 2 1/2 years when I was hormone sensitive (starting 2017). That is the first drug they give to people whose ADT starts to rise after treatment, Or even before treatment If aggressive. I became castrate resistant while on Zytiga. You can’t do that unless you start off castrate sensitive.

Not sure where you saw that it was just approved for hormone sensitive, but that is just not correct.

Jump to this post

Replies to "To: @thmssllvn Zytiga has been used for hormone sensitive patients for a long time, Probably from..."
thmssllvn | @thmssllvn | Jul 12 8:01pm

Yes Zytiga (abireterone) was approved in 2018 for hormone sensitive pts.

VIEW AND REPLY
northoftheborder | @northoftheborder | Jul 13 5:27am

The OP seems to have non-metastatic castrate-sensitive prostate cancer (nmCSPC). I can't find anywhere that says Abiraterone (Zytiga) is approved for that, but I may have missed something.

As @jeffmarc and @thmssllvn wrote, Abiraterone has been approved for metastatic castrate-sensitive prostate cancer (mCSPC) for quite a few years. Apalutamide (Erleada), Enzalutamide (Xtandi), and Darolutamide (Nubeqa) are also approved for mCSPC.

VIEW AND REPLY